• Mashup Score: 2
    COLCORONA: a challenging viewpoint - 3 year(s) ago

    by Fernando Botto, MD, MSc During 2020, most research was focused on powerful and modern anti-inflammatory drugs, unfortunately expensive and not widely available for everyone. Colchicine is a chea…

    Source: CARDiOmics Club
    Categories: Cardiologists, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of lamelaspablo
      lamelaspablo

      RT @ferbotto: COLCORONA: a challenging viewpoint https://t.co/ICWoIOLYuz a través de @cardiomicsclub

  • Mashup Score: 5
    Ticagrelor vs Prasugrel ISAR-REACT 5: A lesson learned - 4 year(s) ago

    Pablo Lamelas – One of the top surprises from ESC congress 2019 was ISAR-REACT 5 trial, which concluded that in acute coronary syndromes Prasugrel was superior to Ticagrelor for efficacy with…

    Source: CARDiOmics Club
    Categories: Cardiologists, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of lamelaspablo
      lamelaspablo

      @djc795 @CMichaelGibson This commentary was published a year ago and im still in the same thinking path... debatable, but ignoring isar react 5 not the solution of some limitations either. Still, ESC rec not strong right? https://t.co/gO9zFqJF6e

  • Mashup Score: 4
    Critical appraisal of Randomized Controlled Trials before #ACC2020 - 4 year(s) ago

    This course is for free Dates: March 2020 Day 1: Wednesday 25th Day 2: Thursday 26th Time: to be determined next Monday morning according to votes Length: 1 hour lecture, 30 minute discussion (90 m…

    Source: CARDiOmics Club
    Categories: Cardiologists
    Tweet Tweets with this article
    • Profile photo of lamelaspablo
      lamelaspablo

      Ready for critically appraising Late-Breaking clinical trials from #ACC2020? @cardiomicsclub will offer 2 free modules of RCT critical appraisal this coming week (dates, time, links, agenda in this thread). No need to sign up, just show up with link below https://t.co/3IoMOVf40G

  • Mashup Score: 0
    New TAVR studies: Weak design not the solution for small trials - 4 year(s) ago

    Pablo Lamelas – In TCT 2019 two trials testing different TAVR designs were presented: SCOPE I (ACURATE neo vs Sapien 3) and Portico IDE trial (Portico vs other devices available). Although th…

    Source: CARDiOmics Club
    Categories: Cardiologists
    Tweet Tweets with this article
    • Profile photo of lamelaspablo
      lamelaspablo

      @GilbertTangMD @mirvatalasnag @CRT_meeting @ron_waksman @ZeroTLR @djc795 @azeemlatib @saraceciliamtz @DocSavageTJU @cardioPCImom @adityadoc1 @Pooh_Velagapudi Was presented in #TCT2019 and this was our commentary, title probable speaks by its own https://t.co/vmPJjdtIZD regulatory research vs clinical decision-making research

  • Mashup Score: 1
    CARDiOmics Club - 4 year(s) ago

    Critical Appraisal of Cardiovascular Research

    Source: CARDiOmics Club
    Categories: Cardiologists
    Tweet Tweets with this article
    • Profile photo of lamelaspablo
      lamelaspablo

      RT @ferbotto: We celebrate that 2019 was the startup of https://t.co/dHgoh6zLGN aiming to create a place for critical appraisal of CV resea…

  • Mashup Score: 2
    Readdressing the validity of Repeat Revascularization outcome in PCI vs CABG trials - 4 year(s) ago

    Pablo Lamelas – In the last decades multiple trials comparing the efficacy of PCI vs CABG incorporated repeat revascularization in the primary composite outcome, which favoured CABG repeatedl…

    Source: CARDiOmics Club
    Categories: Cardiologists
    Tweet Tweets with this article
    • Profile photo of lamelaspablo
      lamelaspablo

      Readdressing the validity of repeat revascularization as an outcome measure in #PCI Vs #CABG. For readers in a hurry: 1) visit @cardiomicsclub https://t.co/MOd2nZUeML 2) go to @JACCJournals and listen podcast https://t.co/HyPMTWm7n4 3) read this thread! (Laziest!)